Your doubled donations helped us raise over £45,000! Thank you!
Cure Parkinson's joined the Big Give Christmas Challenge last week- the UK’s biggest match-funding campaign - and thanks to you, our wonderful supporters, we're delighted to say we've raised a fabulous £45,822 to support our upcoming phase 3 trial of ambroxol for Parkinson's.
A diagnosis of Parkinson’s is life changing. Our Information Hub provides resources recommended to us by people living with Parkinson’s to help you live well with Parkinson’s and discover how you can take part in trials and surveys.
In Parkinson’s a protein called alpha-synuclein, which is abundant in nerve cells, begins clumping together (or aggregating) and it is believed that this process could be toxic. Cure Parkinson's is investigating how this and other key biochemical pathways and events contribute to the progression of Parkinson's. Thanks to our supporters, we’re funding research into the most promising therapeutic areas.
In 2017 results of a large phase 2 clinical trial showed that exenatide, a drug used to treat diabetes, may slow the progression of Parkinson’s. This trial added further evidence to exenatide’s potential as a drug that might interrupt the progression of Parkinson’s; it paved the way for the large phase 3 clinical trial that is now underway. Cure Parkinson’s is co-funding two sub-studies in this promising phase of research into exenatide for Parkinson’s.
PD Frontline is a remote study offering online genetic testing for people with Parkinson’s, so they can be referred to appropriate clinical trials and other studies. The registration process is designed to be quick and easy to navigate, and it only takes 10 minutes to complete!
Alison Anderson was diagnosed with early onset Parkinson’s in 2015, aged 46. Originally from Dundee, Scotland, Alison lives in Cheltenham with her husband and three sons. Undeterred by her condition, Alison has taken on some major cycling challenges to raise funds and awareness for Cure Parkinson's.